A Wearable Biosensor Patch for Non-Invasive Monitoring for Patients Undergoing Abdominal or Chest Surgery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCity of Hope Medical Center

About this trial

This clinical trial tests the feasibility and safety of a wearable biosensor patch for non-invasive monitoring for patients undergoing abdominal or chest surgery. Wearable biosensor patches have been developed by researchers to provide a non-invasive way to monitor substances that are normally checked using blood tests. This may reduce the need for frequent blood draws. The patches use gentle electrical stimulation to produce sweat and tiny built-in sensors to measure substances such as glucose, creatinine, and markers of inflammation, as well as oxygen and carbon dioxide levels. The wearable biosensor patch may be a feasible and safe way to monitor patients undergoing abdominal or chest surgery.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Scheduled to have an elective abdominal or thoracic operation with anticipated post-operative hospitalization ≥ 3 days

Willingness to provide sweat samples, complete surveys, and permit review of medical records for research use

Ability to consent to the study procedures

Disqualifiers

Carbachol or pilocarpine allergy

Adhesive/tape allergy

Damaged or irritated skin on one or both wrists that prohibits placement of the biosensor and sweat collecting devices

Pregnant women

Trial design

Treatments tested in this trial

  • Biospecimen Collection
  • Electronic Health Record Review
  • Interview
  • Survey Administration
  • Wearable Biosensor Patch

Treatment groups

20 Participants
are divided into 1 treatment group

Sponsors and collaborators

City of Hope Medical Center

Lead sponsor

National Cancer Institute (NCI)

Collaborator